Abiopharma

🔍 Cousin Laetitia (Executive)

Company: INSULET CORP (PODD)

Report Date: 2025-09-08

Detailed Transactions and Holdings:

• Acquired 541 shares of Common Stock at $276.36 per share (Direct)
  Date: 2025-09-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,431.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 256 shares of Common Stock at $166.6 per share (Direct)
  Date: 2025-09-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,687.00 | transaction_form_type: 4
• Sold 797 shares of Common Stock at $348.81 per share (Direct)
  Date: 2025-09-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,890.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 541 shares of Employee Stock Option (Right to Buy) at $276.36 per share (Derivative)
  Date: 2025-09-08 | Code: M | Expires: 2033-02-28 | equity_swap_involved: 0 | shares_owned_after: 542.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 256 shares of Stock Option (Right to Buy) at $166.62 per share (Derivative)
  Date: 2025-09-08 | Code: M | Expires: 2034-02-27 | equity_swap_involved: 0 | shares_owned_after: 3,876.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Includes 93 shares acquired under the Insulet Corporation Stock Purchase Plan since the date of the Reporting Person's last Section 16 filing.
• F2: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $348.40 to $348.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
• F3: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.